Who We Are

Frédéric Champavère, Managing Partner Europe | Founder and Former President Pharma Omnium, Former President Janssen-Cilag (Johnson&Johnson), Former President Eli Lilly France

Lorraine Marchand, Co-Director | CEO of Ocular Proteomics; Former COO of Clinilabs; Former Executive Director at Bristol Myers Squibb

Pamela Yih, Co-Director | President Pamela Y-F Yih, Inc; Former Director at Bristol Myers Squibb

Geert Cauwenbergh, PhD, Advisory Board Member | Chairman of BIO New Jersey | Chairman and CEO of RHEI Pharmaceuticals; Founder, Former Chairman and CEO of Barrier Therapeutics (listed, then sold)

Tamar Howson, Advisory Board Member | Advisory Board Member of BIO New Jersey | Member of JSB-Partners; Former SVP Corporate and Business Development at Bristol Myers Squibb; Former SVP and Director of Worldwide Business and Corporate Development at SmithKline Beecham

Jerry Sanders, Advisory Board Member | Founder and Managing Director of San Francisco Science; Founder and former CEO of BaFF (sold), ArteriA (sold), X-Cardia (sold), S3 (sold)

Thierry Teil, MD, Advisor | Executive Vice President at UCB Pharmaceutical

Jerome Chevallier, PharmD, Advisor | Dermo-Cosmetics Expert